ConductScience.org, home

Paper40736616

MRPL15 as a Key Gene in the Malignant Proliferation of LUAD.

Wang Z and 7 others. Biochem Genet, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. MRPL15 as a Key Gene in the Malignant Proliferation of LUAD. Papers, record 40736616. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40736616

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
MRPL15 as a Key Gene in the Malignant Proliferation of LUAD.
PubMed
Journal
Biochem Genet
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang ZZhuoCai
2Qian YYunFeng
3Lai XXuWen
4Cui WWenZhi
5Luo JJingXia
6Zeng WWeiPeng
7He WWenYuan
8Liao MMing

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell ProliferationMajor topic
Ribosomal ProteinsMajor topic
Adenocarcinoma of LungMajor topic
Lung NeoplasmsMajor topic
Mitochondrial ProteinsMajor topic
Humans
Gene Expression Regulation, Neoplastic
Cell Line, Tumor
Female
Biomarkers, Tumor
Male
Ki-67 Antigen
Middle Aged

Source PubMed

Download CSV of topics

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138506034The role of HMGA2 in activating the IGFBP2 expression to promote angiogenesis and LUAD metastasis via the PI3K/AKT/VEGFA signaling pathway.Neoplasma2024https://conductscience.org/library/papers/38506034PubMed
226295375The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes.J Thorac Oncol2015https://conductscience.org/library/papers/26295375PubMed
321642859
Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.
J Thorac Oncol2011https://conductscience.org/library/papers/21642859PubMed
437407805The role of the mitochondrial ribosomal protein family in detecting hepatocellular carcinoma and predicting prognosis, immune features, and drug sensitivity.Clin Transl Oncol2024https://conductscience.org/library/papers/37407805PubMed
533934540MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.Cancer Med2021https://conductscience.org/library/papers/33934540PubMed
622913371
Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification.
Arch Pathol Lab Med2013https://conductscience.org/library/papers/22913371PubMed
732987154Expression analysis of mammalian mitochondrial ribosomal protein genes.Gene Expr Patterns2020https://conductscience.org/library/papers/32987154PubMed
831935514A significant decrease of BAFF, APRIL, and BAFF receptors following mesenchymal stem cell transplantation in patients with refractory rheumatoid arthritis.Gene2020https://conductscience.org/library/papers/31935514PubMed
930504444RNA sequencing data integration reveals an miRNA interactome of osteoarthritis cartilage.Ann Rheum Dis2019https://conductscience.org/library/papers/30504444PubMed
1038331898UPP1 promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment.Nat Commun2024https://conductscience.org/library/papers/38331898PubMed
117773933Small adenocarcinoma of the lung. Histologic characteristics and prognosis.Cancer1995https://conductscience.org/library/papers/7773933PubMed
1230104001Diagnosis of lung tumor types based on metabolomic profiles in lymph node aspirates.Cancer Treat Res Commun2018https://conductscience.org/library/papers/30104001PubMed
1324472852Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.Am J Surg Pathol2014https://conductscience.org/library/papers/24472852PubMed
1429565987PhosphoLipid transfer protein (PLTP) exerts a direct pro-inflammatory effect on rheumatoid arthritis (RA) fibroblasts-like-synoviocytes (FLS) independently of its lipid transfer activity.PLoS One2018https://conductscience.org/library/papers/29565987PubMed
1533415023Classify multicategory outcome in patients with lung adenocarcinoma using clinical, transcriptomic and clinico-transcriptomic data: machine learning versus multinomial models.Am J Cancer Res2020https://conductscience.org/library/papers/33415023PubMed
1636186671Prognostic Values From Integrated Analysis of the Nomogram Based on RNA-Binding Proteins and Clinical Factors in Endometrial Cancer.Clin Med Insights Oncol2022https://conductscience.org/library/papers/36186671PubMed
1730132107Implication of total tumor size on the prognosis of patients with clinical stage IA lung adenocarcinomas appearing as part-solid nodules: Does only the solid portion size matter?Eur Radiol2019https://conductscience.org/library/papers/30132107PubMed
1837563591Protein regulator of cytokinesis 1: a potential oncogenic driver.Mol Cancer2023https://conductscience.org/library/papers/37563591PubMed
1929924316Genome-wide association study of familial lung cancer.Carcinogenesis2018https://conductscience.org/library/papers/29924316PubMed
2028978152Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics.Oncotarget2017https://conductscience.org/library/papers/28978152PubMed

See all 33 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42098410Machine learning-based prognostic signature integrating mitochondrial function and programmed cell death patterns in pancreatic adenocarcinoma.Sci Rep2026https://conductscience.org/library/papers/42098410

Source PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
MKI674288PubTator's text mininghttps://conductscience.org/library/genes/4288NCBI Gene
MRPL1529088PubTator's text mininghttps://conductscience.org/library/genes/29088NCBI Gene
RPL156138PubTator's text mininghttps://conductscience.org/library/genes/6138NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40736616

GET https://conductscience.org/api/papers/v1/40736616/references?page=2